$DYAI
Dyadic International Inc Stock $dyai

$dyai Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000121380920000024 Filed on May 14, 2020

Income Statement

Concept	2020 Q2	2020 Q1	2019 Q1
Revenue	$524.3K	$315.4K	$402.5K
YoY Change	34.13%	-21.65%	118.37%
Cost Of Revenue	$624.2K	$278.2K	$327.9K
YoY Change	93.73%	-15.16%	123.35%
Gross Profit	-$99.97K	$37.19K	$74.62K
YoY Change	-245.63%	-50.16%	98.89%
Gross Profit Margin	-19.07%	11.79%	18.54%
Selling, General & Admin	$1.480M	$1.650M	$1.430M
YoY Change	-20.86%	15.38%	10.85%
% of Gross Profit		4436.68%	1916.27%
Research & Development	$1.116M	$755.5K	$692.4K
YoY Change	36.41%	9.11%	20.02%
% of Gross Profit		2031.33%	927.81%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.116M	$755.5K	$692.4K
YoY Change	36.41%	9.11%	20.02%
Operating Profit	-$2.798M	-$2.383M	-$2.441M
YoY Change	-5.52%	-2.41%	9.49%
Interest Expense	$146.6K	$168.4K	$267.0K
YoY Change	-44.83%	-36.93%	43.18%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.650M	-$2.210M	-$2.170M
YoY Change	-1.85%	1.84%	6.37%
Income Tax	$0.00	$0.00	$900.00
% Of Pretax Income
Net Earnings	-$2.651M	-$2.214M	-$2.175M
YoY Change	-1.65%	1.79%	6.46%
Net Earnings / Revenue	-505.74%	-702.07%	-540.4%
Basic Earnings Per Share
Diluted Earnings Per Share	-$96.47K	-$80.51K	-$81.62K
COMMON SHARES
Basic Shares Outstanding	27.47M shares	27.36M shares	26.71M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q2	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$31.83M	$31.28M	$39.75M
YoY Change	-13.72%	-21.31%	-15.05%
Cash & Equivalents	$11.78M	$4.697M	$3.976M
Short-Term Investments	$20.05M	$26.59M	$35.78M
Other Short-Term Assets	$600.0K	$290.0K	$290.0K
YoY Change	200.0%	0.0%	-62.82%
Inventory
Prepaid Expenses
Receivables	$564.7K	$518.6K	$426.0K
Other Receivables	$730.0K	$730.0K	$830.0K
Total Short-Term Assets	$33.73M	$32.82M	$41.31M
YoY Change	-11.25%	-20.55%	-14.19%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$2.520M
YoY Change	-100.0%
Other Assets	$6.116K	$50.49K	$50.95K
YoY Change	-88.14%	-0.91%	-71.69%
Total Long-Term Assets	$6.116K	$2.569M	$551.6K
YoY Change	-99.7%	365.7%	-18.89%
TOTAL ASSETS
Total Short-Term Assets	$33.73M	$32.82M	$41.31M
Total Long-Term Assets	$6.116K	$2.569M	$551.6K
Total Assets	$33.73M	$35.39M	$41.86M
YoY Change	-15.82%	-15.46%	-14.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.144M	$653.4K	$948.1K
YoY Change	18.76%	-31.08%	101.71%
Accrued Expenses	$378.1K	$240.0K	$303.0K
YoY Change	-4.52%	-20.78%	-15.84%
Deferred Revenue	$41.38K	$242.4K	$23.02K
YoY Change	-54.32%	953.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.638M	$1.136M	$1.274M
YoY Change	13.0%	-10.85%	27.41%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.638M	$1.136M	$1.274M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.640M	$1.140M	$1.270M
YoY Change	13.1%	-10.24%	27.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$46.22M	-$43.57M	-$35.22M
YoY Change	21.9%	23.7%
Common Stock	$39.74K	$39.71K	$38.97K
YoY Change	0.94%	1.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$18.90M	$18.90M	$18.90M
YoY Change	-0.16%	0.0%
Treasury Stock Shares
Shareholders Equity	$32.09M	$34.25M	$40.59M
YoY Change
Total Liabilities & Shareholders Equity	$33.73M	$35.39M	$41.86M
YoY Change	-15.82%	-15.46%	-14.26%

Cashflow Statement

Concept	2020 Q2	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$2.651M	-$2.214M	-$2.175M
YoY Change	-1.65%	1.79%	6.46%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.900M	-$1.996M	-$1.410M
YoY Change	32.87%	41.63%	113.32%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$8.930M	$1.700M	$3.010M
YoY Change	327.27%	-43.52%	-2608.33%
Cash From Investing Activities	$8.930M	$1.698M	$3.006M
YoY Change	327.27%	-43.53%	-2544.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.00K	$175.0K	$0.00
YoY Change	-66.67%		-100.0%
NET CHANGE
Cash From Operating Activities	-1.900M	-$1.996M	-$1.410M
Cash From Investing Activities	8.930M	$1.698M	$3.006M
Cash From Financing Activities	50.00K	$175.0K	$0.00
Net Change In Cash	7.080M	-$126.7K	$1.589M
YoY Change	774.07%	-107.97%	-237.61%
FREE CASH FLOW
Cash From Operating Activities	-$1.900M	-$1.996M	-$1.410M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001213809
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	140 Intracoastal Pointe Drive
CY2020Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 404
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Jupiter
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q2	dyai	Collaborative Arrangement Duration Of Agreement CollaborativeArrangementDurationOfAgreement	P2Y
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	dei	Entity File Number EntityFileNumber	000-55264
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	DYADIC INTERNATIONAL, INC.
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-0486747
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	743-8333
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	500616	USD
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	140 Intracoastal Pointe Drive
CY2020Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 404
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Jupiter
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33477
CY2020Q1	dei	City Area Code CityAreaCode	561
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2020Q1	dei	Trading Symbol TradingSymbol	DYAI
CY2020Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27469157	shares
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4696831	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4823544	USD
CY2020Q1	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	26587752	USD
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	29399146	USD
CY2020Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	227146	USD
CY2019Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	329711	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	518601	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	558530	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	250308	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	288495	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	277999	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	32819441	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	35639238	USD
CY2020Q1	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	2518160	USD
CY2019Q4	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	1511636	USD
CY2020Q1	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	0	USD
CY2019Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	250308	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	50489	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51314	USD
CY2020Q1	us-gaap	Assets Assets	35388090	USD
CY2019Q4	us-gaap	Assets Assets	37452496	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	653373	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	943378	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	240003	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	566003	USD
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	242443	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	78644	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1135819	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1588025	USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39722659	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39612659	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27469157	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27359157	shares
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	39713	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	39613	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	96707690	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	96105851	USD
CY2020Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2019Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43565217	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41351078	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	34252271	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	35864471	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35388090	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37452496	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	315372	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	402527	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	278182	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	327903	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	755453	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	692370	USD
CY2020Q1	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	0	USD
CY2019Q1	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	389473	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1653392	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1428067	USD
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-10867	USD
CY2019Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-6034	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	2697894	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	2843847	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2382522	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2441320	USD
CY2020Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	168383	USD
CY2019Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	266962	USD
CY2020Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2214139	USD
CY2019Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2174358	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-2214139	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2175258	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27452490	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26713486	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	35864471	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	426939	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	175000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-2214139	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	34252271	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-2214139	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2175258	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	426939	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	309563	USD
CY2020Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	107256	USD
CY2019Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	32201	USD
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10867	USD
CY2019Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5148	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-102565	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-3981	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-35258	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	106781	USD
CY2020Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	USD
CY2019Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-6249	USD
CY2020Q1	dyai	Increase Decreasein Prepaid Researchand Development IncreaseDecreaseinPrepaidResearchandDevelopment	0	USD
CY2019Q1	dyai	Increase Decreasein Prepaid Researchand Development IncreaseDecreaseinPrepaidResearchandDevelopment	-83112	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10529	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5049	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-292361	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	641799	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-326000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-96606	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	163799	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-117978	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1996345	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1409521	USD
CY2020Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	11652385	USD
CY2019Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	13190855	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	13350000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	16197000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1697615	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3006145	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	175000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	175000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2983	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7177	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-126713	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1589447	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4823544	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2386314	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4696831	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3975761	USD
CY2020Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	0	USD
CY2019Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	6249	USD
CY2020Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:18pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:36pt;text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of these consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amount of assets and liabilities and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the applicable period. Actual results may differ from these estimates under different assumptions or conditions. Such differences could be material to the consolidated financial statements.</span></div>
CY2020Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentrations and Credit RiskThe Company’s financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash and cash equivalents, investment securities, and accounts receivable. At times, the Company has cash, cash equivalents, and investment securities at financial institutions exceeding the Federal Depository Insurance Company (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”) insured limit on domestic currency and the Netherlands’ FDIC counterpart for foreign currency. The Company only deals with reputable financial institutions and has not experienced any losses in such accounts.
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	518601	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	558530	USD
CY2020Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	198554	USD
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	173890	USD
CY2020Q1	us-gaap	Prepaid Insurance PrepaidInsurance	88607	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	101221	USD
CY2020Q1	us-gaap	Prepaid Taxes PrepaidTaxes	1334	USD
CY2019Q4	us-gaap	Prepaid Taxes PrepaidTaxes	2888	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	288495	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	277999	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4663390	shares
CY2020Q1	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	590452	USD
CY2019Q4	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	766001	USD
CY2020Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	9782	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	26994	USD
CY2020Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	53139	USD
CY2019Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	150383	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	653373	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	943378	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	162310	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	474388	USD
CY2020Q1	dyai	Accrued Researchand Developmentin Process Current AccruedResearchandDevelopmentinProcessCurrent	20035	USD
CY2019Q4	dyai	Accrued Researchand Developmentin Process Current AccruedResearchandDevelopmentinProcessCurrent	69795	USD
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	57658	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	21820	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	240003	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	566003	USD
CY2020Q1	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	613790	USD
CY2019Q1	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	585487	USD
CY2020Q1	dyai	Research And Development Expense Contracted Services Related Party ResearchAndDevelopmentExpenseContractedServicesRelatedParty	0	USD
CY2019Q1	dyai	Research And Development Expense Contracted Services Related Party ResearchAndDevelopmentExpenseContractedServicesRelatedParty	389473	USD
CY2020Q1	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	123638	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4696831	USD
CY2020Q1	dyai	Income Tax Expense Benefit Valuation Allowance Reversal IncomeTaxExpenseBenefitValuationAllowanceReversal	1001233	USD
CY2019Q1	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	94762	USD
CY2020Q1	dyai	Research And Development Expense Facilities Overheadand Other ResearchAndDevelopmentExpenseFacilitiesOverheadandOther	18025	USD
CY2019Q1	dyai	Research And Development Expense Facilities Overheadand Other ResearchAndDevelopmentExpenseFacilitiesOverheadandOther	12121	USD
CY2020Q1	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	755453	USD
CY2019Q1	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	1081843	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	9600000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7200000	USD
CY2019Q4	dyai	Deferred Tax Assets Valuation Allowance Coverage Percent DeferredTaxAssetsValuationAllowanceCoveragePercent	1
CY2020Q1	dyai	Deferred Tax Assets Valuation Allowance Coverage Percent DeferredTaxAssetsValuationAllowanceCoveragePercent	1
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4663390	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4541890	shares
CY2020Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4696831	USD
CY2020Q1	us-gaap	Investments And Cash InvestmentsAndCash	33673423	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	24812	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	154132	USD
CY2020Q1	dyai	Investmentsand Cash Amortized Cost InvestmentsandCashAmortizedCost	33802743	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4823544	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4823544	USD
CY2019Q4	us-gaap	Investments And Cash InvestmentsAndCash	35738787	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	22452	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	17991	USD
CY2019Q4	dyai	Investmentsand Cash Amortized Cost InvestmentsandCashAmortizedCost	35734326	USD
CY2017Q2	dyai	Collaborative Arrangement Paymentfor Researchand Development Agreement CollaborativeArrangementPaymentforResearchandDevelopmentAgreement	1100000	USD
CY2017Q2	dyai	Collaborative Arrangement Paymentfor Researchand Development Agreement CollaborativeArrangementPaymentforResearchandDevelopmentAgreement	1000000	EUR
CY2020Q1	dyai	Prepaid Researchand Development PrepaidResearchandDevelopment	0	USD
CY2019Q4	dyai	Prepaid Researchand Development PrepaidResearchandDevelopment	0	USD
CY2020Q1	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	0	USD
CY2019Q1	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	400000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860390	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860390	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.76
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M12D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	13287932	USD
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	110000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	913000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.24
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	110000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.78
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4663390	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.44
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M24D
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	13017190	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3167983	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.67
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M6D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	11201783	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.78
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	426939	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	309563	USD
CY2020Q1	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock Issued SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStockIssued	100000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.78
CY2019Q1	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock Issued SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStockIssued	0	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	35864471	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	426939	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	175000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-2214139	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	34252271	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	42451169	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	309563	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2175258	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	40585474	USD
CY2019Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2020Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18900000	USD
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	18900000	USD

Files In Submission

Name	View Source	Status
0001213809-20-000024-index-headers.html	Edgar Link	pending
0001213809-20-000024-index.html	Edgar Link	pending
0001213809-20-000024.txt	Edgar Link	pending
0001213809-20-000024-xbrl.zip	Edgar Link	pending
dyai-20200331.htm	Edgar Link	pending
dyai-20200331.xsd	Edgar Link	pending
dyai-20200331_cal.xml	Edgar Link	unprocessable
dyai-20200331_def.xml	Edgar Link	unprocessable
dyai-20200331_g1.jpg	Edgar Link	pending
dyai-20200331_htm.xml	Edgar Link	completed
dyai-20200331_lab.xml	Edgar Link	unprocessable
dyai-20200331_pre.xml	Edgar Link	unprocessable
exhibit311certificatio.htm	Edgar Link	pending
exhibit312certificatio.htm	Edgar Link	pending
exhibit321sec1350certi.htm	Edgar Link	pending
exhibit322sec1350certi.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DYAI
Dyadic International Inc Stock $dyai

2020 Q2 Form 10-Q Financial Statement

#000121380920000024 Filed on May 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI Dyadic International Inc Stock $dyai

2020 Q2 Form 10-Q Financial Statement

#000121380920000024 Filed on May 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI
Dyadic International Inc Stock $dyai